3D Bioprinting Patentable Subject Matter Boundaries

59 Pages Posted: 22 Sep 2017 Last revised: 18 May 2020

Date Written: September 18, 2017


3D bioprinting combines emerging 3D printing technologies with synthetic biology. The promise of 3D bioprinting technology is to fabricate organs for transplantation, treat burn victims with in vivo skin repair, and create wearable microbiomes. 3D bioprinting can successively build, repair, or reproduce living human cells. This capability challenges eligible subject matter doctrine in U.S. patent law because the law has no bright-line standard for patent eligibility for nature-based products. As 3D bioprinting technologies mature, U.S. patent law will need to respond to situations where living and nonliving worlds merge. This Article proposes a “Mixed-Scanned-Transformed” standard to supplement U.S. patent law’s “markedly different characteristics” examination of nature-based products. The markedly different standard arose from the Chakrabarty case in 1980 and is most recently informed by the Myriad case in 2013, but neither case involved merging living and nonliving worlds. By applying this newly proposed standard, 3D bioprinted materials would likely be upheld as patentable subject matter. The proposed “Mixed-Scanned-Transformed” standard and proposed clarity on what is not a “human organism” will allow U.S. patent law to become more bright-line towards 3D bioprinting inventions.

Keywords: 3D Bioprinting, 3D Printing, Synthetic Biology, Markedly Different Characteristics, Patentable Subject Matter

Suggested Citation

Ebrahim, Tabrez, 3D Bioprinting Patentable Subject Matter Boundaries (September 18, 2017). Seattle University Law Review, Vol. 41, No. 1, 2017, Available at SSRN: https://ssrn.com/abstract=3039224

Tabrez Ebrahim (Contact Author)

Lewis & Clark Law School ( email )

10015 S.W. Terwilliger Blvd.
Portland, OR 97219
United States

HOME PAGE: http://https://law.lclark.edu/live/profiles/16710-tabrez-ebrahim

Do you have negative results from your research you’d like to share?

Paper statistics

Abstract Views
PlumX Metrics